InflaRx N.V. is a biotechnology firm based in Germany that develops specialized treatments for inflammatory and autoimmune diseases. Their primary focus is on a monoclonal antibody designed to prevent organ failure in patients suffering from severe sepsis. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?
